Clinical Trial Update: A Study of AMG 732 in Healthy Participants and Participants With Thyroid Eye Disease [Phase 1, Phase 2]

View source ↗

Summary

AMG 732 is being studied in healthy participants and individuals with Thyroid Eye Disease in Phase 1/2 trials, and the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Eye Disease

Drugs mentioned

• AMG 732

Snippet

Sponsor: Amgen | Conditions: Thyroid Eye Disease | Phase 1, Phase 2 | Status: RECRUITING